
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 19, 2023, titled "Marksans Pharma completes the acquisition from Tevapharm India, expanding the existing manufacturing capacity in India".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated April 19, 2023, titled "Marksans Pharma completes the acquisition from Tevapharm India, expanding the existing manufacturing capacity in India".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma